1. Home
  2. WVE vs LMB Comparison

WVE vs LMB Comparison

Compare WVE & LMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$3.69

Market Cap

673.9M

Sector

Health Care

ML Signal

HOLD

Logo Limbach Holdings Inc.

LMB

Limbach Holdings Inc.

HOLD

Current Price

$51.68

Market Cap

579.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
LMB
Founded
2012
1901
Country
United States
United States
Employees
N/A
1400
Industry
Biotechnology: Pharmaceutical Preparations
Engineering & Construction
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
673.9M
579.3M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
WVE
LMB
Price
$3.69
$51.68
Analyst Decision
Strong Buy
Buy
Analyst Count
21
5
Target Price
$17.11
★ $75.00
AVG Volume (30 Days)
★ 3.0M
182.6K
Earning Date
10-27-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 25.68
EPS
N/A
★ 0.76
Revenue
$3,704,000.00
★ $646,804,000.00
Revenue This Year
$46.45
$23.64
Revenue Next Year
N/A
$19.79
P/E Ratio
★ N/A
$67.16
Revenue Growth
★ 149.43
24.68
52 Week Low
$3.04
$40.74
52 Week High
$21.73
$114.95

Technical Indicators

Market Signals
Indicator
WVE
LMB
Relative Strength Index (RSI) 51.82 59.58
Support Level $3.04 $47.80
Resistance Level $4.07 $52.34
Average True Range (ATR) 0.20 1.99
MACD 0.10 0.30
Stochastic Oscillator 76.83 90.27

Price Performance

Historical Comparison
WVE
LMB

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About LMB Limbach Holdings Inc.

Limbach Holdings Inc is a building systems solutions firm that designs, delivers, and maintains mechanical (heating, ventilation, and air conditioning), electrical, plumbing, and controls (MEPC) systems. The Company partners with owners and operators of facilities across healthcare, industrial and manufacturing, data centers, life sciences, higher education, and cultural and entertainment markets. It operates through two segments: Owner Direct Relationships (ODR), which generates maximum revenue and includes owner direct projects, maintenance, and service on MEPC systems; and General Contractor Relationships (GCR), which manages new construction or renovation projects involving MEPC systems awarded by general contractors or construction managers.

Share on Social Networks: